clinical trial · NCT06779552
CardioMEMS HF System Coverage With Evidence Development Study
Abbott Medical Devices·—·recruiting·n = 1,000
Heart FailureCardioMEMS HF System
brief summary
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
started
Feb 7, 2025
primary completion
Mar 1, 2032
completion
Mar 1, 2032
last updated
Apr 3, 2026
detailed description
The CardioMEMS CED Study will assess 2-year HF hospitalization rates and survival for all-cause mortality in heart failure subjects managed with the CardioMEMS HF system, as compared to a contemporaneous control of HF subjects managed without PA pressure-guidance.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol